When it comes to counterfeit drugs, few countries have the regulatory and policing power of the United States. Lack of regulation and enforcement are among the reasons why the World Health Organization (WHO) estimates that between 1% and 10% of … Continue reading
LYON, France – Nearly 200 enforcement agencies across 111 countries have taken part in Operation Pangea VII targeting criminal networks behind the sale of fake medicines via illicit online pharmacies. The operation led to 237 arrests worldwide and the seizure … Continue reading
The National Association of Boards of Pharmacy (NABP) recently issued the Internet Drug Outlet Identification Program Progress Report for State and Federal Regulators: April 2014. The report focuses on two important themes, including the launch of the .PHARMACY generic Top-Level … Continue reading
Since the Drug Quality and Security Act (DQSA) was signed into law by President Obama last year, there has been an enhanced focus on innovative solutions to help tackle the spread of counterfeit drugs. In the first part of this … Continue reading
Last November, the Drug Quality and Security Act (DQSA), which focuses on compounding and a track-and-trace system, was signed into law. In an effort to detect and remove potentially dangerous drugs, including those that could be counterfeit or contaminated, the … Continue reading
Our May newsletter highlights the award CSIP recently received from the U.S. Chamber of Commerce, our participation at a recent Global Forum on Access to Safe Medicines and more. Read our May 2014 Newsletter